FIELD: medicine, gastroenterology, infectious diseases. SUBSTANCE: invention relates to use of derivatives of 1-methyl-carbopenem as an active component for preparing drug used for prophylaxis or treatment of patients with diseases caused by Helicobacter pylori. EFFECT: significant enhancement of treatment of diseases associated with Helicobacter pylori, decreased toxicity. 19 cl, 2 tbl, 1 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2261708C2 |
| CRYSTALLINE PIVALOYLHYDROXYMETHYL-(1R, 5S, 6S)-[(4R)-2-OXO-4--PYRROLIDINYLTHIO]-6-[(1R)-1-HYDROXYETHYL]-1-METHYL-1-CARBAPE--NE-2-EME-3-CARBOXYLATE AND METHOD OF ITS SYNTHESIS | 1993 |
|
RU2090567C1 |
| TETRAZOLE DERIVATIVE-CONTAINING OPHTHALMIC SOLUTIONS | 2003 |
|
RU2318493C2 |
| CRYSTALLINE DERIVATIVES OF 1-METHYLCARBAPENEM | 2000 |
|
RU2214411C2 |
| COMBINED AGENTS FOR GLAUCOMA TREATMENT | 2004 |
|
RU2299067C2 |
| 1-METHYLCARBAPENEM DERIVATIVES, METHOD OF PREPARING THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF ANTIBACTERIAL EFFECT | 1996 |
|
RU2160737C2 |
| DERIVATIVES OF SPIROPIPERIDINE, MEDICINAL AGENT, METHOD OF PROPHYLAXIS OR TREATMENT | 1999 |
|
RU2184735C2 |
| METHOD OF PRODUCING CARBAPENEM DERIVATIVES OR THEIR 4-NITROBENZYL ESTERS | 0 |
|
SU1501922A3 |
| 1-METHYLCARBAPENEM OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS, COMPOSITION, METHOD OF PROPHYLAXIS OR TREATMENT OF PATIENT WITH BACTERIAL INFECTION | 1997 |
|
RU2162088C2 |
| CARBOPENEM DERIVATIVES AND A METHOD OF THEIR SYNTHESIS | 1993 |
|
RU2097383C1 |
